Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial

Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s software/display footer revision was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:38:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:30:58.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no visible changes to study details or page layout.
    Difference
    0.1%
    Check dated 2026-03-28T01:40:38.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:41:43.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous v3.4.1. This appears to be a minor metadata update with no substantive changes to the study content or displayed information.
    Difference
    0.1%
    Check dated 2026-02-13T07:45:12.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 with no visible changes to page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:33:43.000Z thumbnail image

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.